Pfizer's stock is down 2.44% today following the announcement of its 2026 revenue guidance, projecting revenues between $59.5 billion and $62.5 billion and adjusted earnings per share of $2.80 to $3.00. This outlook reflects weaker contributions from COVID products and highlights the impact of cost-saving initiatives and newer pipeline assets.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
